Novo Nordisk is to launch “connected” insulin pens, responding for demands from patients for devices able to communicate with glucose monitoring systems and glucose meters.

general manager of Novo Nordisk UK. "Our smart connected insulin pens aim to empower people to better understand their diabetes management, have more informed conversations with their doctor and ...

A recent media report stated ‘Novo Nordisk to discontinue Human Mixtard, India’s largest selling insulin. Human Mixtard pen is under price control and is a Rs. 800 crore brand in India for the company ...